ABLE Financial Group »

Haemonetics Corporation shares owned by ABLE Financial Group

Quarter-by-quarter ownership of Haemonetics Corporation (HAE) shares owned by ABLE Financial Group from 13F filings

Historical chart of ABLE Financial Group investment in Haemonetics Corporation

Tip: Access up to 7 years of quarterly data

All positions including Haemonetics Corporation held by ABLE Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Haemonetics Corporation by ABLE Financial Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $620k 7.3k 85.51
2023-09-30 $506k 5.6k 89.58

More positions owned by ABLE Financial Group

First Tr Exchange-traded Risng Divd Achiv (RDVY)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Ishares Tr Msci Eafe Etf (EFA)
Spdr Ser Tr S&p 400 Mdcp Val (MDYV)
Apple (AAPL)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Rus Mid Cap Etf (IWR)
Ishares Tr Core Us Aggbd Et (AGG)
Vaneck Etf Trust Long Muni Etf (MLN)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Microsoft Corporation (MSFT)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Ishares Core Msci Emkt (IEMG)

View all positions for ABLE Financial Group

Top funds holding Haemonetics Corporation

Vanguard Group
Neuberger Berman Group
Wellington Management Company
Franklin Resources
Royce & Associates
Dimensional Fund Advisors
Westfield Capital Management Company
Btim
Fisher Investments
Robeco Investment Management
Charles Schwab Investment Management
Allspring Global Investments Holdings
Bank of New York Mellon
T. Rowe Price Associates
Norges Bank Investment Management

View all funds holding Haemonetics Corporation